Navigation Links
Citywide study shows racial disparities in emergency stroke treatment
Date:7/1/2011

Washington, D.C., June 30, 2011 A citywide study published online in today's issue of Stroke: Journal of the American Heart Association demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke.

According to the study's results, significantly fewer black patients receive the drug tPA than whites because of delays in seeking emergency care and the presence of medical conditions that exclude them from receiving the treatment. On the other hand, racial bias in doctors' treatment decisions do not appear to be a factor.

Amie Hsia, MD, medical director of the Stroke Center at Washington Hospital Center and assistant professor in Georgetown University's Department of Neurology, led the study that looked at 1,044 patients treated for stroke from Feb. 1, 2008 to Jan. 31, 2009 at seven acute-care hospitals in the District of Columbia.

Of the patients studied, 775 (80%) were black, and 198 (20%) were white. Only three percent of the black patients received intravenous tPA, the best available treatment, versus 10 percent of the white patients. Formally known as tissue plasminogen activator, tPA has been demonstrated to improve stroke outcomes by breaking up the clot that is blocking the blood flow to the brain.

In order for tPA to be effective, a patient must be treated within three hours of the onset of symptoms and show disabling deficits such as pronounced weakness or severe speech difficulty. Additionally, patients can be ineligible for tPA if they have had a recent stroke, a history of a brain bleed or blood pressure that's too high to safely administer the treatment.

According to the study, the vast majority of black patients are ineligible for the treatment once they arrive at the hospital in large part because of the delay in seeking treatment and the effects of poorly controlled stroke risk factors such as high blood pressure or a recent stroke that made them unsafe candidates for treatment. For those eligible for tPA, there were no statistical differences in the race of those who received treatment, indicating that race was not a factor in whether doctors administered tPA to eligible patients.

The study falls in line with one published online in the same journal on May 5, 2011, also from Dr. Hsia, which reveals that blacks more often called friends or family first instead of 911 when they experienced stroke symptoms, often leading to a delay in treatment and poor outcomes.

"This finding is, on one hand, reassuring to us as providers because it shows no bias on the part of those treating the patients as the reason for disparities in the administration of tPA," said Dr. Hsia. "However, it also highlights the crucial need for more effective education targeted to our urban black population on the symptoms of stroke and actions they must take in order to get proper treatment right away."


'/>"/>

Contact: So Young Pak
soyoung.pak@medstar.net
202-877-2748
Washington Hospital Center
Source:Eurekalert

Related medicine news :

1. Citywide smoking ban contributes to significant decrease in maternal smoking, pre-term births
2. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
3. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
4. TV drama can be more persuasive than news program, study finds
5. Study carried out into biological risks of eating reptiles
6. Neuroimaging study may pave way for effective Alzheimers treatments
7. Study finds racial gaps continue in heart disease awareness
8. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
9. First blinded study of venous insufficiency prevalence in MS shows promising results
10. Soothing infants with food focus of childhood obesity study
11. People with anxiety disorder less able to regulate response to negative emotions, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology: